LSC Recent Webinars on BIO
-
Achieve Pharma 4.0 With Next Generation Software-Defined Manufacturing
11/5/2025
Explore how software-defined manufacturing is helping companies overcome legacy system challenges, improve OEE by up to 25%, and accelerate batch release cycles while maintaining compliance.
-
Enhancing Viral Vector Sterile Filtration: Process Efficiency And GMP Alignment
11/4/2025
Explore filtration strategies that improve viral vector yield and quality, with insights on AAV and lentivirus workflows, plus practical guidance for implementing PUPSIT in line with requirements.
-
Faster Tech Transfers Through Seamless Digital Transformation
10/30/2025
Manual process documentation slows innovation. Learn how modular libraries and digital connectivity enable faster, error-resistant execution, bridging the gap between process design and automation.
-
Developing Your Risk-Based Approach To Single-Use System Integrity
10/29/2025
Explore how a holistic approach to single-use system integrity can strengthen contamination control, improve operational efficiency, and meet evolving regulatory expectations in manufacturing.
-
Optimize DNA Clearance In High-Salt, GMP-Grade Purification Processes
10/28/2025
Explore how salt-active endonucleases overcome DNA clearance challenges in viral vector purification by digesting down to 3–5 nucleotides and performing reliably in high-salt conditions.
-
Strategies For Enhancing Bioprocessing Productivity
10/27/2025
New complex therapeutics demand a shift from traditional bioprocessing. Learn how innovative strategies and resin technologies can help you manage costs and efficiently scale production.
-
The Case For Optimized And Excipient GMP Cell Culture Solutions
10/27/2025
Learn how optimized, customizable formulations and Excipient GMP manufacturing streamline development, ensuring quality and consistency for a de-risked path to the clinic.
-
Smarter CMC Strategies To Accelerate Next-Gen Biologics To The Clinic
10/23/2025
Learn how process design and cross-functional collaboration mitigate risks and accelerate the path from early development to FIH manufacturing through real-world case studies of practical approaches.
-
Unlocking Allogeneic Cell Therapy: Exploring Durable Approaches
10/22/2025
Learn how genome engineering and iPSCs are being used to overcome the critical challenges of durability and host immune clearance in both clinical and preclinical settings for allogeneic cell therapies.
-
Enhancing Non-Viral CAR T Manufacturing With Electroporation And Microbubble T Cell Isolation
10/22/2025
Unlock superior non-viral CAR T manufacturing outcomes by combining gentle microbubble T cell isolation with advanced electroporation. See how this approach boosts cell viability and transfection efficiency.